Advertisement

Topics

Companies Related to "A Study of RO5045337 in Patients With Solid Tumors" [Most Relevant Company Matches] - Page: 2 RSS

07:37 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "A Study of RO5045337 in Patients With Solid Tumors" found in our extensive corporate database of over 50,000 company records.

Showing "Study RO5045337 Patients With Solid Tumors" Companies 26–50 of 4,700+

Relevant

Solid Dosage Training, Inc.

Solid Dosage Training is a California Corporation offering both introductory and single subject seminars on 26 different solid dosage manufacturing topics. We also lecture with the Center for Professional Advancement’s Institute of Applied Pharmaceutical Science. We travel the world training operators, staff and management is solid dosage and hard shell encapsulation.Mr. Rowley is grateful to Wa...


Direct Therapeutics, Inc.

Direct Therapeutics, Inc. is a development-stage pharmaceutical company using its patented Solvent-Facilitated Perfusion technology to create new drugs for the localized and regional treatment of solid-tumor cancers. Our products are designed for direct injection to target tissue with minimal invasion of healthy tissue. They contain active ingredients in organic solvent vehicles that facilitate th...

Longboat Clinical

Longboat is a clinical trials software company dedicated to generating better study outcomes by creating a complete support structure for site staff, patients, monitors, and study teams - where protocol compliance becomes easy and instinctive. In the complex world of clinical development, Longboat’s cloud-based site and patient engagement platform emp...


SOLID Datasystems, Inc.

SOLID Datasystems, Inc. pharmacy information systems are used by a wide range of pharmacies to fill millions of prescriptions per year. Explore our site to find out how SOLID/Rx and SOLID/POS can benefit your pharmacy.

GlobalCare Clinical Trials, Ltd

GlobalCare Clinical Trials, Ltd, is the leading global provider of ambulant healthcare services for clinical trials to government agencies and the world’s biopharmaceutical and medical device companies engaged in all phases of product development. GlobalCare provides innovative, GCP-compliant services by conducting selected study visits in the home or...

OncoMed Pharmaceuticals Inc.

OncoMed Pharmaceuticals is pioneering the development of novel therapeutics that target a new class of solid tumor cells, known as "cancer stem cells". The company's technology is based on a recent discovery by its co-founders that cancer stem cells are uniquely responsible for the growth and proliferation of tumors. We are leveraging our advanced understanding of cancer stem cells to identify the...

Allogene Therapeutics, Inc.

Allogene Therapeutics is a biotechnology company with a mission to catalyze the next revolution in cancer treatment through the development of allogeneic chimeric antigen receptor T-cell (CAR T) therapy directed at blood cancers and solid tumors. Founded and led by former Kite Pharma executives who bring unrivaled clinical development acumen in cell therap...

Blaze Bioscience, Inc.

Blaze Bioscience, Inc. is a Seattle-based, privately-held biotechnology company dedicated to developing products that assist surgeons in their quest to improve the lives of cancer patients. The company was founded in 2010 to develop and commercialize the Tumor Paint technology. The first Tumor Paint product candidate, CyTP 007, is under development for bra...

KaloBios Pharmaceuticals, Inc.

KaloBios Pharmaceuticals, Inc., a U.S. based, private monoclonal company, uses its biologic capabilities and its proprietary platform technology to develop first-in-class human antibody therapeutics. The company has multiple programs that have been in seven Phase 1 or 2 clinical trials in the last few years. KB001 is a PEGylated monoclonal antibody fragmen...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

TriSalus Life Sciences

TriSalus Life Sciences, previously known as Surefire Medical, is a privately held medical device firm in Westminster, CO, focused on making the administration of cancer therapies safer and more effective for patients. The company created the Pressure-Enabled Drug Delivery™ (PEDD) technology and is committed to developing other applications of the tech...

GANYMED Pharmaceuticals AG

GANYMED Pharmaceuticals AG is developing monoclonal antibody therapeutics against solid tumors, where current therapies are poor and where there is an overriding medical need. The therapeutic efficacy of current solid cancer therapeutics is severely limited, because their molecular targets are elevated in a subset of a particular cancer but they are also found widely in normal tissues. In contrast...

Cancer Genetics Incorporated

Cancer Genetics Incorporated is a leading genomics company focusing on genetic disease such as leukemia, lymphoma and solid tumors.

Intracel

Intracel is a leading commercial-stage biotechnology company focused on the development of immune therapy to treat cancer. The company’s pipeline includes product development programs in active immunotherapy and fully human monoclonal antibodies. Intracel has completed clinical studies in Colon, Renal and Ovarian carcinoma, as well as Melanoma. Business StrategyRestructured company to focus o...

Light Sciences Oncology, Inc.

Light Sciences Oncology (LSO) is developing Aptocine for solid tumors as well as benign neoplasms including benign prostatic hyperplasia (BPH). Besides the Phase 3 trials of Aptocine in HCC and MCRC, LSO is also conducting clinical trials of Aptocine in patients with BPH and in neurofibromatosis, and has clinical or preclinical programs for the Aptocine platform in cardiovascular, ophthalmic, and ...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

Jennerex, Inc.

Jennerex, Inc. is a clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The Company's lead product JX-594 is currently in two mid-stage clinical trials in patients with primary liver cancer -- an international, randomized, Phase 2 dose-response clinical trial, and a Phase 2 study in combina...

Aranesp

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...

Exmovere Holdings, Inc.

Exmovere Holdings, Inc. (Frankfurt: X3M) is focused on government and consumer applications for healthcare, mobility, and security and the practical applications of the study of human emotion. The Chariot, Exmobaby pajamas, and the Telepath wristwatch are instrumental in the build out of this vision as a solid representation of Exmovere's push into enha...

Ayala Pharmaceuticals, Inc.

Ayala Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers. Ayala is broadly developing its product candidates, AL101 and AL102, best-in-class gamma secretase inhibitors, with clinical and nonclinical studies underway in both solid tumors (AL...

OncoRx Pharmaceuticals, Inc.

OncoRx Pharmaceuticals (www.oncorxpharmaceuticals.com) is a pharmaceutical company dedicated to the discovery and development of novel drugs that control tumor metastasis; disrupt proliferation; disrupt sustained directional migration; and downregulate distant tissue invasion of drug-resistant tumor cells. In the near term, the Company is planning clinical...

Solid GT

Solid GT, a subsidiary of Solid Biosciences, is a gene therapy platform focused on developing novel, disease-modifying therapeutics for Duchenne muscular dystrophy. The company’s licensed technology has demonstrated efficacy in various DMD animal models and lead candidates are currently undergoing IND-enabling studies. Founded in 2014, Solid GT is col...

RenovoRx, Inc.

RenovoRx, Inc., based in Silicon Valley, is a medical device company developing novel catheter-based technologies for targeted delivery of fluids to the peripheral vessels. The company’s proprietary, patented RenovoCath™ technology is designed to deliver chemotherapy directly to solid tumors.

Gemin X Pharmaceuticals, Inc.

Gemin X Pharmaceuticals, Inc., specializes in the discovery and development of novel target-based cancer therapeutics. Gemin X's lead product, obatoclax (GX15-070), is a small molecule, pan-inhibitor of Bcl-2 proteins and is currently in Phase 2 clinical trials. Gemin X's second compound GMX1777, is a potent, small molecule that specifically inhibits nicotinamide phosphoribosyl transferase (NAMPRT...

Novelos Therapeutics, Inc.

Novelos Therapeutics, Inc. is a biopharmaceutical company commercializing oxidized glutathione-based compounds for the treatment of cancer and hepatitis. Novelos is seeking to build a pipeline through licensing or acquiring clinical stage compounds or technologies for oncology indications. Our lead compound, NOV-002, has been administered to approximately ...


More From BioPortfolio on "A Study of RO5045337 in Patients With Solid Tumors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks